{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:37Z","timestamp":1787026597012,"version":"build-2736575974"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Liver transplantation (LT) has become the optimal therapeutic strategy for end-stage liver disease. Beyond chronic conditions, acute liver failure (ALF) and the emerging field of transplant oncology have also become critical indications for LT. It is important to note that the systemic and local immunometabolic states in these specific pathologies may differ significantly from those in traditional end-stage liver disease, presenting unique challenges for immune management. With advancements in surgical techniques and perioperative management, the long-term survival rates of patients have significantly improved. However, extended patient survival and an expanding donor pool have unmasked long-term complications such as post-transplant metabolic syndrome (PTMS). Furthermore, the patient\u2019s systemic metabolic state influences both the metabolism of immune cells and the utilization of immunosuppressants, posing severe challenges to patient management. Studies indicate that following liver transplantation, distinct immune cells undergo dynamic adaptive changes in energy metabolism, which directly determine the outcomes of rejection, ischemia-reperfusion injury (IRI), and immune tolerance. This review systematically elucidates the mechanisms of immune cell metabolic remodeling. Furthermore, it explores the translational prospects of targeting immunometabolic pathways to optimize immunosuppressive regimens, mitigating IRI, and establish non-invasive biomarkers for immune monitoring, ultimately providing new insights for improving the long-term outcomes of liver transplant recipients.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1776694","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:18:45Z","timestamp":1775103525000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunometabolic remodeling: new perspectives and strategies for liver transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Longbo","family":"Wang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyang","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengyuan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyue","family":"Du","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanteng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000003085","article-title":"Pattern recognition receptor-reactivity screening of liver transplant patients: Potential for personalized and precise organ matching to reduce risks of ischemia-reperfusion injury","volume":"271","author":"Sosa","year":"2020","journal-title":"Ann Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1420336","article-title":"Fatty acid oxidation in immune function","volume":"15","author":"Kemp","year":"2024","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008957","article-title":"Dynamic metabolic reprogramming in dendritic cells: An early response to influenza infection that is essential for effector function","volume":"16","author":"Rezinciuc","year":"2020","journal-title":"PloS Pathog"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12935-025-03781-3","article-title":"A new era in melanoma immunotherapy: Focus on dcs metabolic reprogramming","volume":"25","author":"Nour","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2833","article-title":"Tlr-driven early glycolytic reprogramming via the kinases tbk1-ikk\u03b5 supports the anabolic demands of dendritic cell activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14149","article-title":"The therapeutic potential of t cell metabolism","volume":"17","author":"Zarrinpar","year":"2017","journal-title":"Am J Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.01.018","article-title":"Metabolism in t cell activation and differentiation","volume":"22","author":"Pearce","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01148.x","article-title":"Distinct metabolic programs in activated t cells: Opportunities for selective immunomodulation","volume":"249","author":"Wahl","year":"2012","journal-title":"Immunol Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes t helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Sci (New York NY)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00641","article-title":"The role of fatty acid oxidation in the metabolic reprograming of activated\u2009t-cells","volume":"5","author":"Byersdorfer","year":"2014","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of t(h)17\/t(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110278","article-title":"Hif1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of th17 and treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: Distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory cd4+ t cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol (Balt Md: 1950)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of cd8+ t cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"Pd-1 alters t-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nature08097","article-title":"Enhancing cd8 t-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory t and t helper 17 cells","volume":"20","author":"Berod","year":"2014","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00323-0","article-title":"The cd28 signaling pathway regulates glucose metabolism","volume":"16","author":"Frauwirth","year":"2002","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0899-9007(97)83008-0","article-title":"Glutamine requirement of proliferating t lymphocytes","volume":"13","author":"Yaqoob","year":"1997","journal-title":"Nutr (Burbank Los Angeles County Calif)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/metabo9110248","article-title":"Quantitative (1)h nmr metabolomics reveal distinct metabolic adaptations in human macrophages following differential activation","volume":"9","author":"Fuchs","year":"2019","journal-title":"Metabolites"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00270","article-title":"Metabolic modulation in macrophage effector function","volume":"9","author":"Diskin","year":"2018","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3389\/fimmu.2014.00420","article-title":"Metabolic reprograming in macrophage polarization","volume":"5","author":"Galv\u00e1n-Pe\u00f1a","year":"2014","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.522037","article-title":"Metabolic reprogramming of macrophages: Glucose transporter 1 (glut1)-mediated glucose metabolism drives a proinflammatory phenotype","volume":"289","author":"Freemerman","year":"2014","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and pgc-1\u03b2 attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase m2 regulates hif-1\u03b1 activity and il-1\u03b2 induction and is a critical determinant of the warburg effect in lps-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ros) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray","year":"2012","journal-title":"Cell Signal"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.04.023","article-title":"The sedoheptulose kinase carkl directs macrophage polarization through control of glucose metabolism","volume":"15","author":"Haschemi","year":"2012","journal-title":"Cell Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.017","article-title":"A broken krebs cycle in macrophages","volume":"42","author":"O\u2019Neill","year":"2015","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.030","article-title":"Krebs cycle reimagined: The emerging roles of succinate and itaconate as signal transducers","volume":"174","author":"Murphy","year":"2018","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1111537","article-title":"Mechanisms of triglyceride accumulation in activated macrophages","volume":"92","author":"Feingold","year":"2012","journal-title":"J Leukocyte Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cmet.2006.06.001","article-title":"Designer macrophages: Oxidative metabolism fuels inflammation repair","volume":"4","author":"Lacy-Hulbert","year":"2006","journal-title":"Cell Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00362.2014","article-title":"Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation","volume":"308","author":"Malandrino","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.1094","article-title":"Arginase induction by suppressors of nitric oxide synthesis (il-4, il-10 and pge2) in murine bone-marrow-derived macrophages","volume":"206","author":"Corraliza","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nri3701","article-title":"Integrating canonical and metabolic signalling programmes in the regulation of t cell responses","volume":"14","author":"Pollizzi","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor myc controls metabolic reprogramming upon t lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2274","article-title":"The interplay between myc and hif in cancer","volume":"8","author":"Dang","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1953217","article-title":"Hypoxia-inducible factor-1alpha protects the liver against ischemia-reperfusion injury by regulating the a2b adenosine receptor","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"key":"B44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mtor regulates the differentiation of helper t cells through the selective activation of signaling by mtorc1 and mtorc2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","article-title":"Mtor, metabolism, and the regulation of t-cell differentiation and function","volume":"249","author":"Waickman","year":"2012","journal-title":"Immunol Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/wasj.2025.391","article-title":"Deciphering the critical roles of the ampk\/mtor signaling pathway in cancer cell metabolism (review)","volume":"7","author":"Alasadi","year":"2025","journal-title":"World Acad Sci J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-017-9169-6","article-title":"The regulation effect of ampk in immune related diseases","volume":"61","author":"Wang","year":"2018","journal-title":"Sci China Life Sci"},{"key":"B48","article-title":"Protective benefits of amp-activated protein kinase in hepatic ischemia-reperfusion injury","volume":"9","author":"Zhang","year":"2017","journal-title":"Am J Trans Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100146","article-title":"Pd-1-mediated inhibition of t cell activation: Mechanisms and strategies for cancer combination immunotherapy","volume":"3","author":"Liu","year":"2024","journal-title":"Cell Insight"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S221340","article-title":"The role of pd-1\/pd-l1 axis in treg development and function: Implications for cancer immunotherapy","volume":"12","author":"Cai","year":"2019","journal-title":"OncoTarg Ther"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.101368","article-title":"Post-liver transplant metabolic syndrome","volume":"14","author":"Choudhury","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.154955","article-title":"Calcineurin signaling regulates human islet {Beta}-cell survival","volume":"285","author":"Soleimanpour","year":"2010","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity-what the Fk","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jhep.2010.01.040","article-title":"Metabolic syndrome and liver transplantation: A review and guide to management","volume":"53","author":"Watt","year":"2010","journal-title":"J Hepatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Therapeutics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2008.12.008","article-title":"Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents","volume":"70","author":"Levitsky","year":"2009","journal-title":"Hum Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15253","article-title":"Systematic review with meta-analysis: Sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma","volume":"49","author":"Grigg","year":"2019","journal-title":"Alim Pharmacol Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2014.03.002","article-title":"Strategies for the management of adverse events associated with mTOR inhibitors","volume":"28","author":"Kaplan","year":"2014","journal-title":"Transplant Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1324","article-title":"Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue","volume":"59","author":"Houde","year":"2010","journal-title":"Diabetes"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2012.752118","article-title":"Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3a gene polymorphism","volume":"43","author":"Chitnis","year":"2013","journal-title":"Xenobiot Fate Foreign Compounds Biol Syst"},{"key":"B62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - Pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14735","article-title":"Effect of lipophilicity on drug distribution and elimination: Influence of obesity","volume":"87","author":"Bruno","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1172\/jci29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1177\/00220345211059418","article-title":"Leptin aggravates periodontitis by promoting M1 polarization via NLRP3","volume":"101","author":"Han","year":"2022","journal-title":"J Dent Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000002147","article-title":"International Liver Transplantation Society consensus statement on immunosuppression in liver transplant recipients","volume":"102","author":"Charlton","year":"2018","journal-title":"Transplantation"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i6.2133","article-title":"Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation","volume":"22","author":"Song","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4285\/ctr.24.0059","article-title":"Advancing immunosuppression in liver transplantation: The role of regulatory T cells in immune modulation and graft tolerance","volume":"38","author":"Han","year":"2024","journal-title":"Clin Transplant Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized controlled trial","volume":"12","author":"De Simone","year":"2012","journal-title":"Am J Transplant"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23437","article-title":"Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma","volume":"51","author":"Toso","year":"2010","journal-title":"Hepatol (Balt Md)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/hep.31520","article-title":"Efficacy and safety of immunosuppression withdrawal in pediatric liver transplant recipients: Moving toward personalized management","volume":"73","author":"Feng","year":"2021","journal-title":"Hepatol (Balt Md)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26426","article-title":"Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients","volume":"58","author":"Ben\u00edtez","year":"2013","journal-title":"Hepatol (Balt Md)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.2014","article-title":"Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants","volume":"307","author":"Feng","year":"2012","journal-title":"JAMA"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015552","article-title":"Regulatory T-cell therapy in transplantation: Moving to the clinic","volume":"3","author":"Tang","year":"2013","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T\u2010cell\u2010based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatol (Balt Md)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1097\/mpg.0000000000002150","article-title":"Diet and exercise in pediatric liver transplant recipients: Behaviors and association with metabolic syndrome","volume":"68","author":"Chambers","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01391.x","article-title":"A randomized trial of exercise and dietary counseling after liver transplantation","volume":"6","author":"Krasnoff","year":"2006","journal-title":"Am J Transplant"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.02.030","article-title":"Simultaneous liver transplant and sleeve gastrectomy provides durable weight loss, improves metabolic syndrome and reduces allograft steatosis","volume":"83","author":"Larson","year":"2025","journal-title":"J Hepatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.04.007","article-title":"Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study","volume":"24","author":"Guo","year":"2024","journal-title":"Am J Transplant"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.06.006","article-title":"Integrating immune check inhibitors in liver transplantation for hepatocellular carcinoma: The right time and the right patient","volume":"24","author":"O\u2019Kane","year":"2024","journal-title":"Am J Transplant"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/lvt.0000000000000715","article-title":"AASLD AST practice guideline on adult liver transplantation: Diagnosis and management of graft-related complications","volume":"9900","author":"Te","year":""},{"key":"B82","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/ti.2024.12330","article-title":"Harnessing immune cell metabolism to modulate alloresponse in transplantation","volume":"37","author":"Noble","year":"2024"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.09.036","article-title":"Preventing allograft rejection by targeting immune metabolism","volume":"13","author":"Lee","year":"2015","journal-title":"Cell Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/bjc.2014.272","article-title":"Profiling and targeting of cellular bioenergetics: Inhibition of pancreatic cancer cell proliferation","volume":"111","author":"Cheng","year":"2014","journal-title":"Br J Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211126","article-title":"Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3389\/fimmu.2020.00572","article-title":"Targeting metabolism as a platform for inducing allograft tolerance in the absence of long-term immunosuppression","volume":"11","author":"Cheng","year":"2020"},{"key":"B87","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/b978-0-12-394309-5.00006-7","article-title":"Cell biology of ischemia\/reperfusion injury","volume":"298","author":"Kalogeris","year":"2012","journal-title":"Int Rev Cell Mol Biol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000001411","article-title":"Innate immune regulations and liver ischemia-reperfusion injury","volume":"100","author":"Lu","year":"2016","journal-title":"Transplantation"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27841","article-title":"Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury","volume":"62","author":"Huang","year":"2015","journal-title":"Hepatol (Balt Md)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02945","article-title":"Acidic microenvironment regulates the severity of hepatic ischemia\/reperfusion injury by modulating the generation and function of Tregs via the PI3K-mTOR pathway","volume":"10","author":"Gan","year":"2019","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158210","article-title":"New insights in mechanisms and therapeutics for short- and long-term impacts of hepatic ischemia reperfusion injury post liver transplantation","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144908","article-title":"Ferroptosis in liver diseases: An overview","volume":"21","author":"Capelletti","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103258","article-title":"Cellular and molecular mechanisms of hepatic ischemia-reperfusion injury: The role of oxidative stress and therapeutic approaches","volume":"75","author":"George","year":"2024","journal-title":"Redox Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nature13909","article-title":"Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS","volume":"515","author":"Chouchani","year":"2014","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103227","article-title":"Navigating immune cell immunometabolism after liver transplantation","volume":"160","author":"Zhang","year":"2021","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1075984","article-title":"Editorial: The role of immune cells in hepatic ischemia reperfusion","volume":"13","author":"Ke","year":"2022","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.7150\/thno.82607","article-title":"Hepatocyte HSPA12A inhibits macrophage chemotaxis and activation to attenuate liver ischemia\/reperfusion injury via suppressing glycolysis-mediated HMGB1 lactylation and secretion of hepatocytes","volume":"13","author":"Du","year":"2023","journal-title":"Theranostics"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.010","article-title":"Fasting protects liver from ischemic injury through SIRT1-mediated downregulation of circulating HMGB1 in mice","volume":"61","author":"Rickenbacher","year":"2014","journal-title":"J Hepatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1186\/s12967-023-04564-y","article-title":"Insulin-induced gene 2 protects against hepatic ischemia-reperfusion injury via metabolic remodeling","volume":"21","author":"Wu","year":"2023","journal-title":"J Transl Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.869050","article-title":"Liraglutide attenuates hepatic ischemia-reperfusion injury by modulating macrophage polarization","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63852","article-title":"Hypoxia-inducible factor 1-alpha (Hif-1\u03b1): An essential regulator in cellular metabolic control","volume":"16","author":"Basheeruddin","year":"2024","journal-title":"Cureus"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00587-8","article-title":"The effect of Hif on metabolism and immunity","volume":"18","author":"Taylor","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.10.012","article-title":"The role of Hif in immunity","volume":"42","author":"Gale","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066382","article-title":"Recombinant adiponectin ameliorates liver ischemia reperfusion injury via activating the Ampk\/Enos pathway","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS One"},{"key":"B105","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.immuni.2018.06.016","article-title":"Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit","volume":"49","author":"Nadjsombati","year":"2018","journal-title":"Immunity"},{"key":"B106","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages","volume":"167","author":"Mills","year":"2016","journal-title":"Cell"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.685792","article-title":"Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels*","volume":"291","author":"Cordes","year":"2016","journal-title":"J Biol Chem"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.03.016","article-title":"Memory Cd8+ T cells require increased concentrations of acetate induced by stress for optimal function","volume":"44","author":"Balmer","year":"2016","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.013","article-title":"Food fight: Role of itaconate and other metabolites in antimicrobial defense","volume":"24","author":"Luan","year":"2016","journal-title":"Cell Metab"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5849794","article-title":"Mild hypothermia attenuates hepatic ischemia-reperfusion injury through regulating the Jak2\/Stat3-Cpt1a-dependent fatty acid \u03b2-oxidation","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxid Med Cell Longevity"},{"key":"B112","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41420-023-01636-2","article-title":"Pgc-1\u03b1 inhibits M2 macrophage polarization and alleviates liver fibrosis following hepatic ischemia reperfusion injury","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Death Discov"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12051075","article-title":"Pgc-1\u03b1 is a master regulator of mitochondrial lifecycle and Ros stress response","volume":"12","author":"Abu Shelbayeh","year":"2023","journal-title":"Antioxid (Basel Switzerl)"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.7150\/thno.83163","article-title":"5-aminolevulinate and Chil3\/Chi3l1 treatment amid ischemia aids liver metabolism and reduces ischemia-reperfusion injury","volume":"13","author":"Jin","year":"2023","journal-title":"Theranostics"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.6.3449","article-title":"Regulatory T cells can mediate their function through the stimulation of Apcs to produce immunosuppressive nitric oxide","volume":"176","author":"Chen","year":"2006","journal-title":"J Immunol (Balt Md: 1950)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1172\/jci31892","article-title":"Inhaled No accelerates restoration of liver function in adults following orthotopic liver transplantation","volume":"117","author":"Lang","year":"2007","journal-title":"J Clin Invest"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/635179","article-title":"The hepatoprotective effect of sodium nitrite on cold ischemia-reperfusion injury","volume":"2012","author":"Li","year":"2012","journal-title":"J Transplant"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2022.06.010","article-title":"Current status of biomarkers and molecular diagnostic tools for rejection in liver transplantation: Light at the end of the tunnel","volume":"13","author":"El Sabagh","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-5793","article-title":"3-hydroxykynurenine suppresses Cd4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival","volume":"52","author":"Zaher","year":"2011","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"18663","DOI":"10.1038\/s41598-022-18957-4","article-title":"Metabolomics profiling in acute liver transplant rejection in a pediatric population","volume":"12","author":"Frediani","year":"2022","journal-title":"Sci Rep"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/ijms22041921","article-title":"Tryptophan metabolism via kynurenine pathway: Role in solid organ transplantation","volume":"22","author":"Zulpaite","year":"2021"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.12659\/aot.913800","article-title":"Metabolomic characterization of human model of liver rejection identifies aberrancies linked to cyclooxygenase (Cox) and nitric oxide synthase (Nos)","volume":"24","author":"Skill","year":"2019","journal-title":"Ann Transplant"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1847484","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1776694\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:16:17Z","timestamp":1776683777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1776694\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":122,"alternative-id":["10.3389\/fimmu.2026.1776694"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1776694","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1776694"}}